Skip to main content

Table 4 Factors associated with non-receipt of antenatal or intrapartum antiretroviral prophylaxis

From: Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study

  N N (%) with non-receipt Odds ratio (95% CI) Adjusted odds ratio (95% CI) pvalue
Time of maternal HIV diagnosis     
Pre-pregnancy 886 93 (11) 1.00 1.00
1st/2nd trimester 1500 18 (1) 0.10 (0.06–0.17) 0.12 (0.07–0.20) p < 0.001
3rd trimester 617 50 (8) 0.75 (0.52–1.08) 0.79 (0.54–1.15) p = 0.21
Intrapartum 221 68 (31) 3.79 (2.65–5.42) 3.43 (2.34–5.01) p < 0.001
Maternal age     
<25 years 709 69 (10) 1.00 1.00
25–30 years 1453 84 (6) 0.57 (0.41–0.79) 0.87 (0.60–1.25) p = 0.45
≥30 years 1062 76 (7) 0.72 (0.51–1.01) 0.86 (0.59–1.24) p = 0.41
Mode of acquisition     
Non IDU, no IDU sex partner 1829 106 (6) 1.00 1.00
Non IDU, IDU sex partner 728 27 (4) 0.63 (0.41–0.96) 0.60 (0.38–0.93) p < 0.001
IDU 667 96 (14) 2.73 (2.04–3.66) 1.44 (1.03–2.01) p < 0.001
Gestational age at delivery     
≥37 2937 176 (6) 1.00 1.00
<37 287 53 (18) 3.55 (2.54–4.97) 2.21 (1.53–3.18) p < 0.001
Time of delivery     
2000–2001 224 38 (17) 1.00 1.00
2002–2003 488 26 (5) 0.28 (0.16–0.47) 0.23 (0.13–0.41) p < 0.001
2004–2005 978 68 (7) 0.37 (0.24–0.56) 0.37 (0.23–0.60) p < 0.001
2006–2007 1534 97 (6) 0.33 (0.22–0.50) 0.43 (0.28–0.68) p < 0.001
  1. 95%CI – 95% confidence interval